» Articles » PMID: 39020437

Unraveling Epigenomic Signatures and Effectiveness of Electroconvulsive Therapy in Treatment-resistant Depression Patients: a Prospective Longitudinal Study

Overview
Publisher Biomed Central
Specialty Genetics
Date 2024 Jul 17
PMID 39020437
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Electroconvulsive therapy (ECT) benefits patients with treatment-resistant depression (TRD), but the underlying biological processes are unclear. We conducted an epigenome-wide association study in 32 TRD patients undergoing ECT to depict ECT-associated methylation changes. Illness severity and ECT outcomes were assessed with the Montgomery-Åsberg Depression Rating Scale at baseline (T0) and 1 month after its end (T1). Methylation was profiled at T0 and T1 with the Illumina Infinium Methylation EPIC BeadChip array.

Results: Longitudinal T0-T1 analyses showed 3 differentially methylated probes (DMPs) with nominal p values ≤ 10, with 2 annotated in the genes CYB5B and PVRL4. Including covariates, we found 4 DMPs for symptoms variation, annotated in FAM20C, EPB41, OTUB1 and ADARB1, and 3 DMPs for response status, with 2 annotated in IQCE and FAM20C. Regional analysis revealed 54 differentially methylated regions (DMRs) with nominal p value area ≤ 0.05, with 9 presenting adjusted p-value area ≤ 0.10, annotated in MCF2L, SLC25A24, RUNX3, MIR637, FOXK2, FAM180B, POU6F1, ALS2CL and CCRL2. Considering covariates, we found 21 DMRs for symptoms variation and 26 DMRs for response (nominal p value area ≤ 0.05), with 4 presenting adjusted p-value area ≤ 0.10 for response, annotated in SNORD34, NLRP6, GALNT2 and SFT2D3. None remained significant after false discovery rate correction. Notably, ADARB1 variants are associated with suicide attempt in patients with psychiatric disorders, and SLC25A24 relates to conduct disorder. Several DMPs and DMRs are annotated in genes associated with inflammatory/immune processes. Longitudinal analyses on females (n = 22) revealed statistically significant DMRs (adjusted p value area ≤ 0.05) and trend-significant DMRs (adjusted p value area ≤ 0.07) for symptoms variation and response status, annotated in genes related to psychiatric disorders (ZFP57, POLD4, TRIM10, GAS7, ADORA2A, TOLLIP), trauma exposure (RIPOR2) and inflammatory/immune responses (LAT, DLX4, POLD4, FAM30A, H19). Pathway analysis on females revealed enrichment for transcriptional activity, growth factors, DNA maintenance, and immune pathways including IRF7 and IRF2.

Conclusion: Although no significant results were found for the whole cohort, the study provides insights into ECT-associated methylation changes, highlighting DMPs and DMRs related to ECT outcomes. Analyses on females revealed significant DMRs and pathways related to psychiatric disorders and inflammatory/immune processes.

References
1.
McClard C, Kochukov M, Herman I, Liu Z, Eblimit A, Moayedi Y . POU6f1 Mediates Neuropeptide-Dependent Plasticity in the Adult Brain. J Neurosci. 2018; 38(6):1443-1461. PMC: 5815346. DOI: 10.1523/JNEUROSCI.1641-17.2017. View

2.
Yang X, Yu D, Ren Y, Wei J, Pan W, Zhou C . Integrative Functional Genomics Implicates EPB41 Dysregulation in Hepatocellular Carcinoma Risk. Am J Hum Genet. 2016; 99(2):275-86. PMC: 4974066. DOI: 10.1016/j.ajhg.2016.05.029. View

3.
Huang S, Chen Y, Hu Y, Shi Y, Xiao Q, Li Z . Downregulation of MCF2L Promoted the Ferroptosis of Hepatocellular Carcinoma Cells through PI3K/mTOR Pathway in a RhoA/Rac1 Dependent Manner. Dis Markers. 2022; 2022:6138941. PMC: 9626212. DOI: 10.1155/2022/6138941. View

4.
Fraporti T, Contini V, Tovo-Rodrigues L, Recamonde-Mendoza M, Rovaris D, Rohde L . Synergistic effects between ADORA2A and DRD2 genes on anxiety disorders in children with ADHD. Prog Neuropsychopharmacol Biol Psychiatry. 2019; 93:214-220. DOI: 10.1016/j.pnpbp.2019.03.021. View

5.
Du P, Zhang X, Huang C, Jafari N, Kibbe W, Hou L . Comparison of Beta-value and M-value methods for quantifying methylation levels by microarray analysis. BMC Bioinformatics. 2010; 11:587. PMC: 3012676. DOI: 10.1186/1471-2105-11-587. View